Evidence map›Paper›PMID 39411352›Full record

ArticleInternational journal of nanomedicine2024

Vancomycin-Loaded in situ Gelled Hydrogel as an Antibacterial System for Enhancing Repair of Infected Bone Defects.

Shouye Sun, Qian Wang, Bin Zhang, Yutao Cui, Xinghui Si, Gan Wang, Jingwei Wang, Hang Xu, Baoming Yuan, Chuangang Peng

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. TargetingBiofilm · 2025
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shouye SunOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Qian WangDepartment of Otolaryngology, The First Hospital of Jilin University, Changchun, People's Republic of China.
Bin ZhangDepartment of Spinal Surgery, The 964th Hospital of PLA Joint Logistic Support Force, Changchun, People's Republic of China.
Yutao CuiOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Xinghui SiChangchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, People's Republic of China.
Gan WangOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Jingwei WangOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Hang XuOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Baoming YuanOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Chuangang PengOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: During treatment of infected bone defects, control of infection is necessary for effective bone repair, and hence controlled topical application of antibiotics is required in clinical practice. In this study, a biodegradable drug delivery system with in situ gelation at the site of infection was prepared by integrating vancomycin into a polyethylene glycol/oxidized dextran (PEG/ODEX) hydrogel matrix. Methods: In this work, PEG/ODEX hydrogels were prepared by Schiff base reaction, and vancomycin was loaded into them to construct a drug delivery system with controllable release and degradability. We first examined the microstructure, degradation time and drug release of the hydrogels. Then we verified the biocompatibility and in vitro ability of the release system. Finally, we used a rat infected bone defect model for further experiments. Results: The results showed that this antibacterial system could be completely biodegradable in vivo for 56 days, and its degradation products did not cause specific inflammatory response. The cumulative release of vancomycin from the antibacterial system was 58.3% ± 3.8% at 14 days and 78.4% ± 3.2% at 35 days. The concentration of vancomycin in the surrounding environment was about 1.2 mg/mL, which can effectively remove bacteria. Further studies in vivo showed that the antibacterial system cleared the infection and accelerated repair of infected bone defects in the femur of rats. There was no infection in rats after 8 weeks of treatment. The 3D image analysis of the experimental group showed that the bone volume fraction (BV/TV) was 1.39-fold higher ( Conclusion: In summary, this study clearly demonstrates that a clinical strategy based on biological materials can provide an innovative and effective approach to treatment of infected bone defects.

Indexed as

Anti-Bacterial AgentsDextransHydrogelsPolyethylene GlycolsRats, Sprague-DawleyVancomycinAnimalsBone RegenerationDrug Delivery SystemsDrug LiberationMaleRatsAnti-Bacterial AgentsDextransHydrogelsPolyethylene GlycolsVancomycindrug delivery systemhydrogelinfected bone defectsvancomycin

Identifiers

PMID39411352
PMCPMC11476785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.